(Q33374782)

English

Phase Ia/Ib chemo-radiation trial of gemcitabine and dose-escalated thoracic radiation in patients with stage III A/B non-small cell lung cancer.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17409896%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Phase Ia/Ib chemo-radiation trial of gemcitabine and dose-escalated thoracic radiation in patients with stage III A/B non-small cell lung cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17409896%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Antonius A Miller

7

object named as

Antonius A Miller

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17409896%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

L. Douglas Case

5

object named as

L Douglas Case

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17409896%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

author name string

A William Blackstock

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17409896%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Coty Ho

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17409896%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Jerome Butler

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17409896%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

June Fletcher-Steede

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17409896%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

William Hinson

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17409896%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

publication date

1 June 2006

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17409896%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Journal of Thoracic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17409896%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17409896%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17409896%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

434-440

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17409896%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Cancer statistics, 2004

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2931608-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2931608-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized phase II study of cisplatin with gemcitabine or paclitaxel or vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy for stage IIIB non-small-cell lung cancer: cancer and leukemia group B study 9431.

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2931608-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose-escalating conformal thoracic radiation therapy with induction and concurrent carboplatin/paclitaxel in unresectable stage IIIA/B nonsmall cell lung carcinoma: a modified phase I/II trial

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2931608-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Activity of gemcitabine in patients with non-small cell lung cancer: a multicentre, extended phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2931608-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase I-II study of gemcitabine and paclitaxel in advanced non-small-cell lung cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2931608-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The influence of the schedule and the dose of gemcitabine on the anti-tumour efficacy in experimental human cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2931608-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiosensitization produced in vivo by once- vs. twice-weekly 2'2'-difluoro-2'-deoxycytidine (gemcitabine)

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2931608-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhancement of radiation-induced regrowth delay by gemcitabine in a human tumor xenograft model

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2931608-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiosensitization of pancreatic cancer cells by 2',2'-difluoro-2'-deoxycytidine

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2931608-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Maximizing therapeutic gain with gemcitabine and fractionated radiation

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2931608-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of gemcitabine (2',2'-difluorodeoxycytidine) given as a twice weekly schedule to previously untreated patients with non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2931608-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I study of twice-weekly gemcitabine and concurrent thoracic radiation for patients with locally advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2931608-7

7 January 2021

based on heuristic

inferred from DOI database lookup

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2931608-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2931608-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial assessing the combination of gemcitabine and cisplatin in advanced non-small cell lung cancer (NSCLC).

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2931608-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Gemcitabine (GEM) and carboplatin (CBDCA) versus cisplatin (CDDP) and vinblastine (VLB) in advanced non-small-cell lung cancer (NSCLC) stages III and IV: a phase III randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2931608-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized phase II trial of gemcitabine plus irinotecan or docetaxel in stage IIIB or stage IV NSCLC.

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2931608-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase I study of moderate-dose radiation therapy and weekly gemcitabine in patients with locally advanced non-small cell lung cancer not suitable for radical chemoradiation therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2931608-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I trial of weekly gemcitabine and concurrent radiotherapy in patients with inoperable non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2931608-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiation esophagitis: Predictive factors and preventive strategies

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2931608-7

7 January 2021

based on heuristic

inferred from DOI database lookup

"Anatomically-correct" dosimetric parameters may be better predictors for esophageal toxicity than are traditional CT-based metrics.

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2931608-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase II study of weekly gemcitabine and paclitaxel in patients with previously untreated stage IIIb and IV non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2931608-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Three-arm randomized study of two cisplatin-based regimens and paclitaxel plus gemcitabine in advanced non-small-cell lung cancer: a phase III trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group--EORTC 08975.

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2931608-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Gemcitabine in locally advanced and metastatic non-small cell lung cancer: the Central European phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2931608-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A prospective study on lung toxicity in patients treated with gemcitabine and carboplatin: clinical, radiological and functional assessment.

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2931608-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I/IIa study of cisplatin and gemcitabine as induction chemotherapy followed by concurrent chemoradiotherapy with gemcitabine and paclitaxel for locally advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1556-0864%2815%2931608-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1556-0864(15)31608-7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17409896%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17409896%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33374782&oldid=1628428108"